Trials / Completed
CompletedNCT05801757
Continuous Infusion of Remidazolam for Colonoscopic Polypectomy in Elderly Patients
Sedative Effect of Remidazolam Besylate Continuous Pump Infusion for Colonoscopic Polypectomy in Elderly Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To observe the sedative effect of continuous infusion of remidazolam in elderly patients undergoing colonoscopic polypectomy.
Detailed description
To observe the sedative effect of continuous infusion of remidazolam in elderly patients undergoing colonoscopic polypectomy, and to screen the optimal dose of remidazolam, in order to provide a more reasonable and safe sedative and analgesic drug regimen for elderly outpatients undergoing colonoscopic polypectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam | Using two different doses of remidazolam for continuous pumping to maintain anesthetic effect |
| DRUG | Propofol | propofol 2-3mg/kg/h |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2023-04-06
- Last updated
- 2024-08-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05801757. Inclusion in this directory is not an endorsement.